FDA Accepts New Drug Application for Potential ALS Treatment Edaravone

Following up on information released in June about edaravone, an intravenous drug therapy produced by Mitsubishi Tanabe Pharma Corporation, locally based in Jersey City, N.J., with a head office in Osaka, Japan, there has been recent news as to the status of the drug in the U.S.

Continue reading FDA Accepts New Drug Application for Potential ALS Treatment Edaravone